Vipont Pharmaceutical, Inc. is a leading biopharmaceutical company focused on developing innovative therapies to improve the lives of patients worldwide. With a strong commitment to research and development, Vipont Pharmaceutical is dedicated to advancing cutting-edge treatments in areas such as oncology, neurology, and rare diseases. Our mission is to deliver high-quality, safe, and effective medications that address unmet medical needs and drive positive outcomes for patients and healthcare providers.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#37 in Fort Collins, CO

#773 in Colorado

#35,941 in US

Fort Collins, CO, United States of America

Vipont Pharmaceutical, Inc.

Forward Citations = 356

11 inventors:

Ronald J Harkrader (6 out of 8 patents)

Richard L Dunn (5 out of 68 patents)

Arthur J Tipton (4 out of 43 patents)

4. Kenneth C Godowski (3 out of 5 patents)

5. George L Southard (2 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vipont Pharmaceutical, Inc.. Retrieved from https://idiyas.com/company/vipont-pharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]